UPDATE 2-Australia's CSL surges 18% on earnings beat, upbeat plasma business forecast

* CSL underlying profit $3.14 billion, ahead of consensus * Shares surge 18% in their best day since June 2001 * FY27 underlying NPAT growth forecast of 5% * Announces share buy-back of A$1.1 billion

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)